US FDA approves Arrowhead's genetic disorder drug

The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...
KRDO

What you need to know as FDA removes ‘black box’ warning on menopause hormone treatment

The United States Food and Drug Administration (FDA) has removed "black box" warnings on many hormone treatments used to ...

Jeni’s ice cream bars recalled over undeclared wheat, soy allergen, FDA says

A batch of Jeni's Passion Fruit Dreamsicle Ice Cream Bars was recalled because they may contain undeclared wheat and soy, ...
KFGO

UnitedHealth names former US FDA chief Scott Gottlieb to its board

UnitedHealth Group said on Tuesday it had named former U.S. Food and Drug Administration commissioner Scott Gottlieb to its ...
MPR

FDA Approves Redemplo for Familial Chylomicronemia Syndrome

Plozasiran is an apoC-III-directed small interfering ribonucleic acid designed to reduce levels of hepatic and serum apoC-III ...
JD Supra

An Overview of the Over-the-Counter Monograph Drug User Fee Amendments (OMUFA): Policy Areas to Watch

On 2, 2025, President Trump signed H.R. 5371, the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction ...
Opinion
Williamsport Sun-GazetteOpinion

What other newspapers are saying: FDA’s recent performance embarrassing

The Food and Drug Administration shouldn’t be in the news if it’s doing its job right. By that measure the FDA is failing in spectacular fashion. The agency this week is making news for all of the ...
Fierce Healthcare

Former FDA Commissioner Scott Gottlieb joins UnitedHealth Group's board

Former Food and Drug Administration Commissioner Scott Gottlieb, M.D., is joining the board at industry giant UnitedHealth ...
The Manila Times

Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or ...

In June 2024, EPKINLY monotherapy was granted accelerated approval by the FDA for the treatment of R/R FL following two or more lines of systemic therapy. With the results from the confirmatory Phase ...

RFK Jr. discussed scaling back the role of FDA chief Makary, WSJ reports

Trump administration officials, including Health Secretary Robert F. Kennedy Jr., have discussed scaling back the role of ...
Multiple Sclerosis News Today

FDA OKs generic version of Vumerity for relapsing MS

Zydus won final FDA approval to market a generic version of Vumerity for adults with relapsing forms of MS and active SPMS.

I treat menopause and its symptoms, and hormone replacement therapy can help – here’s the science behind the FDA’s decision to remove warnings

(THE CONVERSATION) For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration describing the medication’s risk of serious harms – namely, ...